AT-23 A PHASE II STUDY OF LAPATINIB AND DOSE-DENSE TEMOZOLOMIDE (TMZ) FOR ADULTS WITH RECURRENT EPENDYMOMA: A CERN CLINICAL TRIAL

BACKGROUND: Ependymoma is an uncommon adult primary CNS tumor. Initial treatment includes extensive resection often followed by but there is no standard treatment for recurrent disease. Molecular studies show most tumors have ErbB2 overexpression and unmethylated MGMT promoter status. We developed a...

詳細記述

保存先:
書誌詳細
主要な著者: Gilbert, Mark, Yuan, Ying, Wani, Khalida, Wu, Jimin, Omuro, Antonio, Lieberman, Frank, Robins, H. Ian, Gerstner, Elizabeth, Wu, Jing, Wen, Patrick, Mikkelsen, Tom, Armstrong, Terri, Aldape, Ken
フォーマット: Artigo
言語:Inglês
出版事項: Oxford University Press 2014
主題:
Abstracts
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC4217801/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/nou237.23
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料